Friday, May 1, 2026

Jang Nara’s Heartwarming Donation: Helping Homeless Pets Find Hope!

Actress Jang Nara donates 20 million won to Angels' Nest, supporting animals and showcasing her commitment to their care.

North Korea’s Warship Sank at Launch—Now It’s Back in Just 23 Days

North Korea successfully launched a new 5,000-ton destroyer, the Kang Kon, emphasizing naval power and advanced technology post-damage.

TREASON IN SEOUL: Activists Jailed For Saving North Korean Lives While The Government Sits SILENT

North Korea-focused group members face prosecution for launching balloons with anti-regime propaganda, violating safety laws.

Sang Hyuk Seo

How Ildong Bioscience is Revolutionizing Health Supplements at Vitafoods India 2026

Ildong Bioscience participated in the 2026 Vitafoods India expo, showcasing innovative health products and seeking partnerships in the healthcare sector.

IMCAS 2026: Discover How Sijibio Secured Over 70.4 Million USD in Global Contracts

CGBIO showcased its collagen stimulator at IMCAS 2026, securing contracts worth 101.5 billion KRW to strengthen its global market position.

3Billion Partners with Austin: What This Means for Rare Disease Diagnostics in the U.S.

3Billion partners with Austin for a new lab to enhance rare disease diagnostics and expand its U.S. market presence.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

CM Hospital’s thynC System: The Future of Patient Monitoring and Safety in Healthcare

Daewoong Pharmaceutical launches thynC, an AI-powered monitoring system at CM Hospital to enhance patient safety and healthcare quality.

Top News

- Our Sponsors Ad -

Follow us